HIPAA Journal

FEBRUARY 23, 2022

Title II: Preventing health care fraud and abuse; administration simplification; medical liability reform. Title III: Tax-related health provisions governing medical savings accounts. Title V: Revenue offsets governing tax deductions for employers. Title IV: Application and enforcement of group health plan requirements.

HIPAA 92

HIPAA Fraud Health Insurance Medicaid 92

YouCompli

APRIL 13, 2022

The government contended the inducements were in the form of free blood glucose testing supplies and waiver of co-payments and deductibles for insulin. The whistleblower who brought this to the attention of the government worked in the business office and was privy to the waiving of copayments. million dollars.

Medicare 40

Medicare Medicare Governance Compliance 40

Health Care Law Brief

APRIL 11, 2022

As early as 2002 and as highlighted in recent guidance , OIG has explained its longstanding concerns relating to the offering of incentives intended to induce beneficiaries to obtain federally reimbursable items and services when those incentives have been cash or cash equivalents. The OIG highlighted four specific reasons. Key Takeaways.

Fraud 52

Fraud Medicare Medicare Compliance 52

HIPAA Journal

MARCH 30, 2022

Had the level of abuse and fraud in the healthcare industry been allowed to continue, tens of billions of dollars would have been lost to unscrupulous actors. However, when HIPAA was passed, the standards governing health care data, patients´ rights, and the flow of information were still several years away. In March 1996, Rep.

HIPAA 123

HIPAA Fraud Health Insurance Health Care Reform 123

Drug & Device Law

NOVEMBER 10, 2022

3, 2002) (to be published), the California Court of Appeal held that federal law preempts state law failure-to-warn claims alleging that branded and generic drug manufacturers did not ensure that patients received FDA-approved Medication Guides for amiodarone, a heart medicine. In Amiodarone Cases , No. A161023, 2022 WL 16646728 (Cal.

FDA 52

FDA Doctors Fraud Governance 52

Drug & Device Law

JANUARY 30, 2023

470 (1996), was decided – removing express preemption as a defense for manufacturers of §510(k) products So defendants moved on fraud on the FDA under an implied preemption theory and won. Mensing , 564 U.S. Mensing , 564 U.S. Lohr , 518 U.S. Davidowitz , 312 U.S. Davidowitz , 312 U.S.

FDA 72

FDA Fraud Governance Medicare 72